Literature DB >> 21428713

Antiplasmodial and cytotoxic activity of coumarin derivatives from dried roots of Angelica gigas Nakai in vitro.

Hyung-In Moon1, Jai-Heon Lee, Young-Choon Lee, Kyoung-Sook Kim.   

Abstract

The butanol-soluble fraction of the dried root of Angelica gigas exhibited significant protection against chloroquine-sensitive strains of Plasmodium falciparum using the parasite lactate dehydrogenase assay method. Using antiplasmodial activity-guided fractionation, five coumarins, marmesinin (1), nodakenin (2), skimmin (3), apiosylskimmin (4), and magnolioside (5), were isolated and evaluated for in vitro antiplasmodial activity, as well as for their cytotoxic potential on SK-OV-3 cancer cell lines. Compounds 1 and 5 showed notable growth inhibitory activity against chloroquine-sensitive strains of P. falciparum with IC(50) values of 5.3 and 8.2 μM. The compounds showed no significant cytotoxicity (IC(50) > 100 μM) toward the SK-OV-3 cancer cell line. This is the first report on the antiplasmodial activity of these coumarin derivatives from the dried root of A. gigas.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21428713     DOI: 10.3109/08923973.2011.559248

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  3 in total

1.  Cancer Chemoprevention with Korean Angelica: Active Compounds, Pharmacokinetics, and Human Translational Considerations.

Authors:  Junxuan Lü; Jinhui Zhang; Li Li; Cheng Jiang; Chengguo Xing
Journal:  Curr Pharmacol Rep       Date:  2015-04-19

2.  Total Coumarins from Hydrangea paniculata Protect against Cisplatin-Induced Acute Kidney Damage in Mice by Suppressing Renal Inflammation and Apoptosis.

Authors:  Zhang Sen; Ma Jie; Yang Jingzhi; Wang Dongjie; Zhang Dongming; Chen Xiaoguang
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-06       Impact factor: 2.629

3.  Skimmin Improves Insulin Resistance via Regulating the Metabolism of Glucose: In Vitro and In Vivo Models.

Authors:  Guoqiang Zhang; Xin Cai; Lingmin He; Dingmei Qin; Hongwen Li; Xiaoming Fan
Journal:  Front Pharmacol       Date:  2020-04-29       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.